The global neurological biomarkers market size is estimated to grow by USD 7.82 billion at a CAGR of 13.01% between 2023 and 2028. The globalization of clinical trials has consistently expanded over the past two decades, which has been credited to numerous components, including organized trials, voluntary members, accessibility of qualified local investigators, improved infrastructure facilities, and the low expense of clinical trials in developing nations.

Know More